New advances in the computational simulation of Aqueous Homogeneous Reactor for medical isotopes production

Aqueous Homogeneous Reactors (AHRs) or simply solution reactors present nowadays a promising alternative to produce medical isotopes, especially 99Mo. The AHR medical production concept has been proposed to produce medical isotopes directly in the fuel solution, resulting in a potentially competitive alternative in comparison with the solid target irradiation method in heterogeneous reactors. Furthermore, the utilization of AHRs for medical isotopes production has been strengthened because of the successful operation of the ARGUS reactor since 1981 and its conversion to low-enriched uranium (LEU) fuel during 2012-2014. Those successes positively influenced in the decisions to construct a Proof-Of-Concept production site based on the ARGUS operational experience in Sarov (500 km from Moscow) and to restore the Argus-FTI at the Umarov Physical and Technical Institute in Dushanbe, Tajikistan. However, demonstrating the viability of the AHRs for medical isotopes requires solving several significant challenges related with the safe operation of these reactors. Consequently, not only for the design, licensing and safe operation of the AHRs, but also for the prediction of accident scenarios it is very important to be able to simulate and predict the behavior of the fuel solutions through a group of relevant physical parameters. Accordingly, this paper aims to show the advances made to improve the predictive capabilities during the multi-physics computational modeling of AHRs.

High Flux Reactor Continued Safe Operation: Time Limited Ageing Analyses

The High Flux Reactor (HFR) is a multipurpose nuclear reactor located in Petten, the Netherlands. With its 45 MWth it is one of the most powerful and versatile research reactors in the world. Its main roles are material irradiation and medical isotopes production. The output of the reactor in terms of medical isotopes is important at a global level (60% of European demand). Every day in the Netherlands alone 30.000 patients are treated using isotopes produced in the HFR. The importance of the HFR dates back in time. The HFR has been in service since 1961. Due to the long life (58 years to date) of the reactor an efficient integrated ageing management program (AMP) is envisaged as it is foreseen that the HFR will continue to operate for a prolonged period of time. The development of the AMP has begun in 2018 (CSO project) and will be completed in view of the IAEA CSO mission. The HFR is the second reactor in the world to undergo this type of IAEA review and one of the objectives of this project is to set a state of the art when it comes to research reactors long term operation. The CSO project foresees four major sections: scoping and screening, development and improvement of plant programs, (re) validation of time limited ageing analyses (TLAAs) and realization of the ageing management program. In this paper the focus will lie on the TLAAs. The applicable TLAAs were scoped starting from the IGALLs TLAAs list. The TLAAs relevant for the HFR are: TLAA fatigue, TLAA reactor vessel, TLAA leak before break, TLAA manufacturing flaws TLAA beryllium and TLAA equipment qualification. The latter was developed in the framework of the equipment qualification plant program and does not figure as an independent TLAA in the CSO project. For each TLAA the principal problematics will be highlighted and the possible solutions illustrated.

New Ion Source Filament for Prolonged Ion Source Operation on A Medical Cyclotron

Cyclotrons are an important tool for accelerator sciences including the production of medical isotopes for imaging and therapy. For their successful and cost-efficient operation, the planned and unplanned down time of the cyclotron needs to be kept at a minimum without compromising reliability. One of the often required maintenance activities is the replacement of the filament in the ion source. Here, we are reporting on a new ion source filament tested on a medical cyclotron and its prolonging effect on the ion source operation.